Navigation Links
Marken Appoints New Directors To Board
Date:3/5/2013

RESEARCH TRIANGLE PARK, N.C., March 5, 2013 /PRNewswire/ -- Marken today announced that it has appointed two independent directors to its Board as a result of Marken's recent restructuring completed on December 21, 2012.  The appointment of Timothy C. Tyson and Michael O'Donnell is the next step in Marken's strategy to focus on serving the global life sciences industry.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO)

Tim Tyson is a veteran leader in the global pharmaceutical market place.  He currently serves as Chairman of the Board of Aptuit LLC, a global pharmaceutical services company based in the US.  He was CEO and President of Valeant Pharmaceuticals Inc. from 2003-2008.  Prior to that, Mr. Tyson held various leadership roles including as President, Global Manufacturing & Supply at GlaxoSmithKline (GSK).  During his 14 years at GSK, he led the Glaxo Dermatology and Cerenex Divisions, the US Marketing Division, and the US Sales Divisions where he launched 32 products, eight of which exceeded $1billion in global sales.  Mr. Tyson is an engineering graduate of the US Military Academy at West Point, and holds a masters degree in public administration from Jackson State University. He has held key positions on the PhRMA Board and the International Society of Professional Engineers (ISPE).

Michael O'Donnell currently serves as Chairman of Verna, a company specializing in infectious control products, and as non-executive Director of Helical Bar plc. a property development firm.  He has served as an independent Director on the Boards of seven companies since 2008 and also acted as a consultant to one of Marken's clients.  Prior to 2008, Mr. O'Donnell was a Managing Director of LGV Capital, a private equity firm, where he worked for more than a decade. He started his career at Morgan Grenfell where he worked for five years after graduating from University College, Dublin with a Bachelor of Commerce degree. 

"We are delighted to welcome Tim and Michael to Marken's Board of Directors," said Wes Wheeler , Marken's Chief Executive Officer.  "These two independent Directors will certainly provide us with an appropriate balance of deep industry and financial experience.  They also bring excellent contacts from the pharmaceutical industry and the UK financial markets, respectively, which will allow us to continue our expansion in the life sciences supply chain market." 

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Announces Global Advisory Board
4. Marken Launches New Global Regulatory Consultation Services
5. Marken Enhances Branch Operations
6. Marken Expands Regulatory And Technical Excellence In Logistics
7. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
8. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
9. Nephros Appoints John C. Houghton as President and Chief Executive Officer
10. Elsevier Appoints New President of Elsevier CPM Resource Center
11. GenWay Biotech Appoints New Vice President of Custom/OEM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
Breaking Medicine News(10 mins):